Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;11(3):308-16.
doi: 10.1007/s11904-014-0214-z.

Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention

M-J Milloy  1 , Julio S G Montaner, Evan Wood
Affiliations

Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention

M-J Milloy et al. Curr HIV/AIDS Rep. 2014 Sep.

Abstract

Contact with the criminal justice system, including incarceration, is a common experience for many people living with HIV/AIDS. Optimism has recently been expressed that correctional facilities could be important locations for treatment-as-prevention (TasP)-based initiatives. We review recent findings regarding the effect of incarceration on patterns of HIV transmission, testing, treatment initiation and retention. We found that the prevalence of HIV infection among incarcerated individuals remains higher than analogous non-incarcerated populations. Recent studies have shown that voluntary HIV/AIDS testing is feasible in many correctional facilities, although the number of previously undiagnosed individuals identified has been modest. Studies have implied enhanced linkage to HIV/AIDS treatment and care in jails in the United States was associated with improvements in the HIV cascade of care. However, for many individuals living with HIV/AIDS, exposure to the correctional system remains an important barrier to retention in HIV/AIDS treatment and care. Future research should evaluate structural interventions to address these barriers and facilitate the scale-up of TasP-based efforts among individuals living in correctional settings.

PubMed Disclaimer

Conflict of interest statement

Drs. Wood and Milloy declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Prevalences of various measures of engagement in HIV/AIDS treatment and care among individuals enrolled in the EnhanceLink study, stratified by gender, during incarceration (a) and six-months after release from incarceration (b), as reported by Meyer et al., [87]
See this image and copyright information in PMC

References

    1. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223. - PMC - PubMed
    1. Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E, et al. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health. 2001;11:243–250. - PubMed
    1. Allwright S. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000;321:78–82. - PMC - PubMed
    1. Amiya RM, Cope JE, Poudel KC, Jimba M. At the intersection of public health and criminal justice systems. Lancet. England; 2013;381:534. - PubMed
    1. Centers for Disease Control and Prevention (CDC) HIV transmission among male inmates in a state prison system--Georgia, 1992–2005. MMWR Morb. Mortal. Wkly. Rep. 2006;55:421–426. - PubMed

Publication types

MeSH terms

Substances